ABSN provides a wide range of services under the professional management with Global Multi-National Biopharmaceutical expertise and hands-on experience.
Our experience includes Quality and Regulatory guidelines in compliance with cGMP, cGLP, cGCP, ICH, USP, EP and JP in Bacterial and Viral Vaccines, r-DNA derived Proteins, and Monoclonal Antibodies.
We have 20,000SFT R&D Facility and expected 50-100 Acres land and signed AP CARL PPP with government. We will be developing patented & proprietary platform technology driven
We are building our own biopharmaceutical cGMP manufacturing with disposable/modular facility and required investment US $ 25M. Use of funds are for building our own facility & R&D and Product Development, QA/QC/RA/BD/Marketing
Strong technical/business/marketing expert management that worked global MNCs/Launched blockbuster Biologics/Bio-drugs cost effectively /quality/timely
5 yrs expected to be US $ 250,000,000, Exit: IPO listing and or M&A Merger/Acquisition
| Model | Temperature Range | Internal Volume | External Dimension | Net Weight | Full Load Weight | Endurance Time |
|---|---|---|---|---|---|---|
| NAV-DURAB1 | -80 ~ -70℃ | 12L | 325×320×470mm | 7.5kg | 15kg | ≥120hrs |
| NAV-DURAB2 | -80 ~ -70℃ | 31L | 325×450×630mm | 14kg | 25kg | ≥250hrs |
| NAV-DURAB3 | -80 ~ -70℃ | 46L | 325×550×750mm | 21kg | 35kg | ≥300hrs |